Vaccinating 130Cr people with injectable Covaxin a challenge: Bharat Biotech
Published
Published
Even as India's first indigenous coronavirus vaccine Covaxin is entering its third phase of human trials, Bharat Biotech on Monday..
The key vaccines India is banking on are from Oxford/AstraZeneca, Novavax and J&J and the earliest efficacy data is expected by the..